NanoString Technologies Inc. introduces the nCounter Cancer Copy Number Assay Kit, one of the latest additions to its nCounter Analysis System. With the nCounter Cancer Copy Number Assay Kit, users gain precise analysis of 86 genes commonly amplified or deleted in a range of cancer types, including BRCA, PIK3CA, AKT, MYC and PTEN. The kit enables accelerated sample throughput for validation studies, enhanced copy number studies using FFPE samples and provides the latest content for human microRNA assays. The nCounter Cancer Copy Number Assay Kit is optimized for analysis of FFPE samples.  

 

 

 

NanoString Technologies Inc.

(888) 358-6266

www.nanostring.com